220 related articles for article (PubMed ID: 33789109)
1. Epigenomic tensor predicts disease subtypes and reveals constrained tumor evolution.
Leistico JR; Saini P; Futtner CR; Hejna M; Omura Y; Soni PN; Sandlesh P; Milad M; Wei JJ; Bulun S; Parker JB; Barish GD; Song JS; Chakravarti D
Cell Rep; 2021 Mar; 34(13):108927. PubMed ID: 33789109
[TBL] [Abstract][Full Text] [Related]
2. Epigenomic and enhancer dysregulation in uterine leiomyomas.
Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
[TBL] [Abstract][Full Text] [Related]
3. Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas.
Moyo MB; Parker JB; Chakravarti D
Nat Commun; 2020 Feb; 11(1):1019. PubMed ID: 32094355
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
[TBL] [Abstract][Full Text] [Related]
5. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers.
Mehine M; Kaasinen E; Heinonen HR; Mäkinen N; Kämpjärvi K; Sarvilinna N; Aavikko M; Vähärautio A; Pasanen A; Bützow R; Heikinheimo O; Sjöberg J; Pitkänen E; Vahteristo P; Aaltonen LA
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1315-20. PubMed ID: 26787895
[TBL] [Abstract][Full Text] [Related]
6. Identification of uterine leiomyoma-specific marker genes based on DNA methylation and their clinical application.
Sato S; Maekawa R; Yamagata Y; Tamura I; Lee L; Okada M; Jozaki K; Asada H; Tamura H; Sugino N
Sci Rep; 2016 Aug; 6():30652. PubMed ID: 27498619
[TBL] [Abstract][Full Text] [Related]
7. Submucous and outer myometrium leiomyomas are two distinct clinical entities.
Brosens J; Campo R; Gordts S; Brosens I
Fertil Steril; 2003 Jun; 79(6):1452-4. PubMed ID: 12798900
[No Abstract] [Full Text] [Related]
8. Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells.
Malik M; Webb J; Catherino WH
Clin Endocrinol (Oxf); 2008 Sep; 69(3):462-70. PubMed ID: 18248652
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.
Laganà AS; Vergara D; Favilli A; La Rosa VL; Tinelli A; Gerli S; Noventa M; Vitagliano A; Triolo O; Rapisarda AMC; Vitale SG
Arch Gynecol Obstet; 2017 Nov; 296(5):855-867. PubMed ID: 28875276
[TBL] [Abstract][Full Text] [Related]
10. Comparing regulation of the connexin43 gene by estrogen in uterine leiomyoma and pregnancy myometrium.
Andersen J
Environ Health Perspect; 2000 Oct; 108 Suppl 5():811-5. PubMed ID: 11035987
[TBL] [Abstract][Full Text] [Related]
11. Expression Profiling of lncRNAs, miRNAs, and mRNAs and Their Differential Expression in Leiomyoma Using Next-Generation RNA Sequencing.
Chuang TD; Khorram O
Reprod Sci; 2018 Feb; 25(2):246-255. PubMed ID: 28587571
[TBL] [Abstract][Full Text] [Related]
12. Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas.
Conconi D; Redaelli S; Lissoni AA; Cilibrasi C; Perego P; Gautiero E; Sala E; Paderno M; Dalprà L; Landoni F; Lavitrano M; Roversi G; Bentivegna A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557274
[TBL] [Abstract][Full Text] [Related]
13. Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium.
Hou P; Zhao L; Li Y; Luo F; Wang S; Song J; Bai J
Mol Hum Reprod; 2014 Feb; 20(2):148-54. PubMed ID: 24130091
[TBL] [Abstract][Full Text] [Related]
14. [Uterine fibromas: classification and physiopathology].
Christin-Maitre S; Wirthner D
J Gynecol Obstet Biol Reprod (Paris); 1999 Nov; 28(7):707-14. PubMed ID: 10624621
[No Abstract] [Full Text] [Related]
15. Omega-3 fatty acids modulate the lipid profile, membrane architecture, and gene expression of leiomyoma cells.
Islam MS; Castellucci C; Fiorini R; Greco S; Gagliardi R; Zannotti A; Giannubilo SR; Ciavattini A; Frega NG; Pacetti D; Ciarmela P
J Cell Physiol; 2018 Sep; 233(9):7143-7156. PubMed ID: 29574773
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.
Yin P; Roqueiro D; Huang L; Owen JK; Xie A; Navarro A; Monsivais D; Coon JS; Kim JJ; Dai Y; Bulun SE
PLoS One; 2012; 7(1):e29021. PubMed ID: 22272226
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.
Norian JM; Malik M; Parker CY; Joseph D; Leppert PC; Segars JH; Catherino WH
Reprod Sci; 2009 Dec; 16(12):1153-64. PubMed ID: 19700613
[TBL] [Abstract][Full Text] [Related]
18. Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains.
Gopi LK; Kidder BL
Nat Commun; 2021 Mar; 12(1):1419. PubMed ID: 33658503
[TBL] [Abstract][Full Text] [Related]
19. [Cytogenetic subtyping of 139 uterine leiomyoma].
Stern C; Deichert U; Thode B; Bartnitzke S; Bullerdiek J
Geburtshilfe Frauenheilkd; 1992 Dec; 52(12):767-72. PubMed ID: 1490556
[TBL] [Abstract][Full Text] [Related]
20. Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays.
Malik M; Catherino WH
Fertil Steril; 2007 May; 87(5):1166-72. PubMed ID: 17222838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
